| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K02251932 |
| PharmacoGx | BRD-K02251932 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MAPK13 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.07 |
| mRNA | TNFRSF1A | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | RBM34 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | STAT5A | CTRPv2 | pan-cancer | AAC | -0.077 | 0.07 |
| mRNA | DDX39B | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | CTD-2192J16.17 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | CHRNA5 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.07 |
| mRNA | KLHL36 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | SIRT5 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | FAM120C | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
